Abacus Life, Inc. (NASDAQ:ABL) Director Adam Samuel Gusky Purchases 5,000 Shares

Abacus Life, Inc. (NASDAQ:ABL) Director Adam Samuel Gusky bought 5,000 shares of Abacus Life stock in a transaction dated Friday, November 17th. The stock was acquired at an average price of $6.02 per share, with a total value of $30,100.00. Following the purchase, the director now directly owns 22,718 shares of the company’s stock, valued at $136,762.36. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Abacus Life Price Performance

Shares of ABL stock traded up $0.22 during trading hours on Monday, reaching $6.52. The stock had a trading volume of 3,525 shares, compared to its average volume of 22,372. The stock has a fifty day simple moving average of $6.75. The company has a current ratio of 7.24, a quick ratio of 2.32 and a debt-to-equity ratio of 0.72. Abacus Life, Inc. has a 12 month low of $5.47 and a 12 month high of $11.43.

Institutional Investors Weigh In On Abacus Life

An institutional investor recently bought a new position in Abacus Life stock. Barclays PLC acquired a new position in Abacus Life, Inc. (NASDAQ:ABL) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 6,924 shares of the company’s stock, valued at approximately $47,000. Hedge funds and other institutional investors own 16.02% of the company’s stock.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.